Under construction – not a live service
Sign in
Taking people in PakistanNo phase

Comparing Remote and In-Person Rehabilitation for Thinking Skills After Stroke

Compares remote rehabilitation with in-person rehabilitation for thinking problems in stroke survivors.

Plain-language title generated from the registry record
Registry title: Tele-Rehabilitation vs Conventional Rehabilitation for Cognitive Improvement in Stroke Survivors.

Key facts

Where
Islamabad, PakistanSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 50 and 80 years old?

Source: NCT07504276, who can take part

Where in Pakistan

  • Riphah International UniversityIslamabad, PakistanTaking people

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Riphah International University
Trial code
NCT07504276
Record updated
3 April 2026
Original description
This study aims to:Read full original descriptionShow less

Comparison Of Tele-Rehabilitation Versus Conventional Rehabilitation To Improve Cognition Among Stroke Survivor.

This study aims to:

* Compare tele-rehabilitation and conventional rehabilitation for cognitive improvement after stroke. * Evaluate changes in cognitive function using standardized assessment tools. * Determine whether tele-rehabilitation is as effective as conventional therapy. * Improve evidence-based rehabilitation strategies for stroke survivors.

Inclusion: Adults with age 50-80; Diagnosed with ischemic or hemorrhagic stroke within subacute to chronic phase; Moca Score 10-25 score atleast; For tele-rehab must accessible to a digital device.

Exclusion: History of neurodegenerative disorder e.g Alzheimer's Disease and Parkinson's Disease; Severe Cognitive Impairment; Lack of access to or inability to use a digital device.

ClinicalTrials.gov NCT07504276